News Author: Doug Brunk Publish date: March 7, 2024
Children with versus without atopic dermatitis were more likely to experience difficulties with learning and memory.
News Author: Doug Brunk Publish date: March 5, 2024
FDA approved letibotulinumtoxinA-wlbg, which has been used in South Korea, to treat glabellar lines in adults.
News Author: Doug Brunk Publish date: March 4, 2024
Knowledge about one's risk for a second primary invasive melanoma over time remains incomplete.
News Author: Doug Brunk Publish date: March 4, 2024
The study “highlights the importance of a symptom-based approach when treating psoriasis, ” the authors wrote.
News Author: Doug Brunk Publish date: March 4, 2024
Parents may turn to TikTok for information about IHs, but little is known about the quality of videos on the social media platform related to the t...
News Author: Doug Brunk Publish date: February 23, 2024
The study population consisted of 18,618 psoriasis cases and 55,854 controls.
News Author: Doug Brunk Publish date: February 22, 2024
The mean treatment duration was 13.1 weeks and the mean posttherapy follow-up occurred after a mean of 7.8 weeks.
News Author: Doug Brunk Publish date: February 21, 2024
The most common noninfectious dermatologic condition among the 425 children and adolescents was acne, followed by eczema.
News Author: Doug Brunk Publish date: February 20, 2024
The development comes on the heels of the phase III OLYMPIA trial program.
News Author: Doug Brunk Publish date: February 15, 2024
The development is based on data from two phase 3 clinical trials and interim results from a long-term extension trial.
News Author: Doug Brunk Publish date: February 14, 2024
“Future steps involve establishing evidence-based clinical practice guidelines that consider drug efficacy, safety profiles, and costs,” the author...
News Author: Doug Brunk Publish date: February 13, 2024
“This is an opportunity to improve state health, quality improvement projects, help providers, and gain recognition as a center of excellence,” Dr....
News Author: Doug Brunk Publish date: February 13, 2024
Most study participants rated their cellulite improvement as good and 78.6% said that the treatment was relatively pain-free.
News Author: Doug Brunk Publish date: February 12, 2024
"Patients can consider trying a 'use test' on the inner forearm before applying to the surgical site," the authors wrote.
News Author: Doug Brunk Publish date: February 8, 2024
The study involved 389 board-certified dermatologists and 450 primary care physicians in 39 countries.